SCHEMBL7358115

SCHEMBL7358115

CSc1ncc(C(=O)Cl)cc1OC1CCOC1

nearest known ligand 0.43

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
PDE4D Q08499 16/20 0.43
PDE4A P27815 8/20 0.43
PDE4B Q07343 8/20 0.43
PDE4C Q08493 8/20 0.43
CHEK1 O14757 1/20 0.38
CNR2 P34972 1/20 0.37
GRM5 P41594 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7352171 0.89 PDE4D (0.44) PDE4DPDE4APDE4BPDE4CCHEK1
SCHEMBL7355853 0.87 PDE4D (0.45) PDE4DPDE4APDE4BPDE4CCHEK1
SCHEMBL7361220 0.84 PDE4B (0.40) PDE4DPDE4APDE4BPDE4C
SCHEMBL7353934 0.82 PDE4B (0.50) PDE4DPDE4APDE4BPDE4CCHEK1
SCHEMBL7354110 0.79 PDE4D (0.50) PDE4DPDE4APDE4BPDE4C
SCHEMBL7352658 0.73 PDE4D (0.71) PDE4DPDE4APDE4BPDE4C
SCHEMBL7352652 0.73 PDE4D (0.71) PDE4DPDE4APDE4BPDE4C
SCHEMBL7361578 0.73 PDE4D (0.71) PDE4DPDE4APDE4BPDE4C
SCHEMBL7362666 0.73 KMT2A (0.47) PDE4DPDE4APDE4BPDE4C
SCHEMBL17220370 0.73 OPRK1 (0.43) PDE4DPDE4APDE4BPDE4CGRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0741707-B1 SUBSTITUTED AROMATIC COMPOUNDS AS c.AMP PHOSPHODIESTERASE- AND TNF-INHIBITORS RHONE POULENC RORER LTD (GB) 1998-04-01 EP disclosed
EP-0741707-A1 SUBSTITUTED AROMATIC COMPOUNDS AS c.AMP PHOSPHODIESTERASE- AND TNF-INHIBITORS RHONE-POULENC RORER LIMITED (GB) 1996-11-13 EP disclosed
WO-1995020578-A1 SUBSTITUTED AROMATIC COMPOUNDS AS c.AMP PHOSPHODIESTERASE- AND TNF-INHIBITORS RHONE-POULENC RORER LIMITED (GB) 1995-08-03 WO disclosed